Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-06-26
2007-06-26
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C548S113000
Reexamination Certificate
active
10652733
ABSTRACT:
Disclosed are compounds of the formula Iand pharmaceutically acceptable salts and prodrugs thereof, wherein W, R1, R2, R7, R8, R9and R10are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 5525625 (1996-06-01), Bridges et al.
patent: 6469004 (2002-10-01), Barrett et al.
patent: 6506798 (2003-01-01), Barrett et al.
patent: 2003/0078428 (2003-04-01), Barrett et al.
patent: 2003/0092748 (2003-05-01), Barrett et al.
patent: WO 95/03286 (1995-02-01), None
patent: WO 98/43960 (1998-10-01), None
patent: WO 99/01421 (1999-01-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 00/40235 (2000-07-01), None
patent: WO 00/40237 (2000-07-01), None
patent: WO 00/41505 (2000-07-01), None
patent: WO 00/41994 (2000-07-01), None
patent: WO 00/42002 (2000-07-01), None
patent: WO 00/42003 (2000-07-01), None
patent: WO 00/42022 (2000-07-01), None
patent: WO 00/42029 (2000-07-01), None
patent: WO 00/68201 (2000-11-01), None
patent: WO 01/05390 (2001-01-01), None
patent: WO 01/05391 (2001-01-01), None
patent: WO 01/05392 (2001-01-01), None
patent: WO 01/05393 (2001-01-01), None
patent: WO 01/68619 (2001-09-01), None
patent: WO 02/06213 (2002-01-01), None
patent: WO 02/18319 (2002-03-01), None
patent: WO 02/44166 (2002-06-01), None
Friis et al., European Journal of Pharmaceutical Sciences, 4, (1996), pp. 49-59.
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Hurley T. Brian
Koch Kevin
Lyssikatos Joseph P.
Marlow Allison L.
Wallace Eli M.
Array BioPharma Inc.
Moore John R.
Stockton Laura L.
LandOfFree
N3 alkylated benzimidazole derivatives as MEK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N3 alkylated benzimidazole derivatives as MEK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N3 alkylated benzimidazole derivatives as MEK inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3882963